Connect with us

Technology

Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann’s Abode of Chaos as a ‘total work of art’, the global headquarters of Artprice by Artmarket.

Published

on

PARIS, March 24, 2025 /PRNewswire/ — La Demeure du Chaos (“The Abode of Chaos” – dixit the New York Times) was conceived in 1999 as “a mirror of our world” by thierry Ehrmann. Besides his many business accomplishments, his certified biography in Who’s Who In France describes Ehrmann as a ‘visual artist since 1980’.  https://imgpublic.artprice.com/img/wp/sites/11/2025/02/2025-Biographie_de_Thierry_Ehrmann-Who-s-Who-In-France.pdf

The Abode of Chaos is managed by a contemporary art museum baptised “Organe” and located in the village of Saint-Romain-Au-Mont-d’Or just outside Lyon, France.

This unique open-air museum spans 7,555m² and features a one-of-a-kind museum trail set in the heart of nature. Open to the public free of charge, it was conceived as a total work of art, ensuring accessibility and inclusion for all audiences, in line with the vision of its founder and creator, thierry Ehrmann. It is classified by the Prefecture as an ERP open-air museum. Since its opening in 2006, the Contemporary Art Museum has received 2.5 million visitors free of charge, 25% of whom are from outside France.

In 25 years, the Abode of Chaos has been the subject of nearly 3,600 written and audiovisual press reports from 72 countries. Its activities are followed around the world by more than 10.9 million subscribers on its social media accounts and it counts 720,000 signatories to the petition for its preservation and recognition by France’s public authorities.  

The Abode of Chaos has three imposing buildings dating back to 1630 that have been completely re-sculpted in an alchemical transmutation that gave birth to nearly 7,200 distinct works of art created by thierry Ehrmann. Each work has its original name, its original medium and its original shape. There are 4,500 laser-sculpted steel artworks, some weighing several hundred tons. There are also portraits, paintings, street artworks, mural engravings, installations, digital artworks created with AI, works of land art and an all-encompassing electronic system, which together constitute a ‘total work of art’:

https://ftp1.serveur.com/abodeofchaos_singular_architecture.pdf

France’s Minister of Culture, Madame Rachida Dati has officially recognized in a letter dating 20 March, 2025 thierry Ehrmann’s Abode of Chaos as a total work of art in the following terms:

“Dear Sir,

For several years you have been practicing a proteiform artistic activity alongside your energetic development of Artprice, the company you founded.

Not long ago, you drew the attention of one of my predecessors and my ministerial services (DRAC and DGCA) to the complex situation surrounding the product of your artistic activity: the Abode of Chaos.

Originally an old farm in the Monts du Lyonnais, you made the property your personal residence as well as the headquarters of your company Artprice. At the same time, you developed a multi-faceted and abundant artistic project on the entire site, part of which has National Historical Monument protection, called “La Demeure du Chaos” (Abode of Chaos). This project, which integrates the architecture of the existing building as well as its surroundings, while preserving and respecting the remains of an old Protestant cemetery, is a total work of art, in perpetual evolution. It’s primary artistic objective is to reflect the historical and societal convulsions at the end of the 20th century and the promises and uncertainties of our 21st century. The work is both indoors and outdoors, integrating public and private spaces, notably those dedicated to the daily activities of your company.

Its integrated contemporary art museum offers a hallucinatory and fascinating promenade through the recesses of human memory via portraits of the prominent personalities of our modern era, as well as key quotes, sculptures and architectural extensions that modify the existing buildings. Repurposed car and plane wrecks also play a key role, alongside contemporary ‘factories’ installed in the park.

I would like to inform you that my ministerial department officially recognizes the value of this unique work, which I understand is in perpetual motion and will only stop evolving when you are no longer.”

According to Madame Dati, thierry Ehrmann’s work, “is in line with great ‘total works of art’ like Postman Cheval’s Ideal Palace and the Cyclops in Milly la Forêt…

By this letter I wish to inform you that the Ministry of Culture recognizes the artistic value of the work already created and encourages you to continue it.”  

Recognition by public authorities constitutes the highest point in the process of protecting the artworks of the Abode of Chaos and, with regard to the law, it is the principal factor that triggers the work’s inclusion in the History of Art and its preservation for posterity. The different protection measures constitute a subsidiary factor, while the Minister offers a range of legal solutions to allow the transmission of the Abode of Chaos to future generations:

“I also hope that a dialogue can be initiated with State Services and in particular with the Regional Prefecture and the Regional Office of Cultural Affairs (DRAC), in both directions.

The first concerns allowing greater access to the Abode by extending the openings hours that you already practise.

The second concerns implementing the right conditions to ensure the sustainability, conservation and accessibility of the Abode to future generations. I will also ask my services, both central and decentralized, to collaborate with your teams to examine the various legal frameworks that could be used to allow the perennity and transmission of the Abode to future generations: endowment fund, a protected foundation, or a foundation recognized as being of public utility, or any other suitable device.”

With great emotion, upon reading this letter, thierry Ehrmann – founder of Artprice, historian and visual sculptor – cannot help but reflect on the extensive study he dedicated to the sculptor Constantin Brancusi:

“Exactly a century ago, the U.S. High Court (Brancusi/USA) redefined the cognitive value of a work of art through a landmark trial involving Constantin Brancusi’s The Bird in Space. Today, after 25 years of legal struggle, France, through its Minister of Culture, Madame Rachida Dati, has officially recognized the value of my work, defining it as unique through my artistic creation embodied in The Abode of Chaos and its total work of art. Furthermore, it acknowledges that my work is in constant evolution and encourages me to continue, while supporting its dissemination, conservation, and sustainability. This moment forms a true ‘mise en abîme’, linking Brancusi’s The Bird and his portrait painted in my studio at the heart of The Abode of Chaos. It represents both my Great Alchemical Work and my 45 years of artistic creation. I receive this recognition with deep gratitude towards the Minister of Culture, her team, and all my long-standing supporters, as we mark the 25th anniversary of the Abode of Chaos. Today, France, through the voice of its Minister of Culture, is writing a new chapter in the history of art.”

The process of recognition and legal protection of the Abode of Chaos relies on in part, on the creation of an in-depth bilingual architectural study titled “The Abode of Chaos: Gesamtkunstwerk & Singular Architecture”. This study is now freely accessible to the public at:

https://ftp1.serveur.com/abodeofchaos_singular_architecture.pdf

The brief description provided in this press release is not exhaustive. The reader is encouraged to consult the typescript for a comprehensive reading of the referenced works.

The study examines the Abode of Chaos from a historical, archaeological, sociological, artistic, architectural and scientific points of view, with the help of international experts, distinguished professors,  and multidisciplinary researchers.

This Study constituted the core requests led by Sandra Béchiche – Director of thierry Ehrmann’s office, in charge of international relations and heritage conservation, for legal protection addressed to the French Ministry of Culture, and more specifically to the General Director of the General Department of Artistic Creation (DGCA) in the person of Christopher Miles, as well as to Marc Drouet, Regional Director of Cultural Affairs Auvergne-Rhône-Alpes (DRAC AURA).

These initiatives began in December 2019 in order to obtain recognition from the public authorities of thierry Ehrmann’s total work of art, and to ensure its sustainability and a peaceful resolution to the 25-year legal dispute initiated by the Commune of Saint-Romain-Au-Mont-d’Or, based on town planning law in the face of artistic creation. This dispute was initially protected by the Malraux laws and later by the law of July 7, 2016, concerning freedom of creation, architecture, and heritage. thierry Ehrmann contributed to this through the legal debate he initiated on the status of the artist in France and the freedom of artistic creation.

The surveys, plans, sections, illustrations, orthophotographs for the complete digitization of the 7200 artworks connected to the buildings, outbuildings and surrounding walls over 7,555 m² (generating a digital heritage of 1.2 Terra-Bytes [1 pixel IPTC/GPS DMS = 1mm]) was carried out in 18 months by Philippe Barthélémy, founder of ICONEM (which has done extensive work of the Bamiyan cliffs, Palmyra site etc.) as well as TT Géomètres Experts Group and its 3D Lab. This work was based on the European Commission’s standards for the digitization and online accessibility of cultural material and digital preservation (2011/711/EU).

The study and the complete digitization of the Abode of Chaos was overseen by martyr heritage specialists led by Dr. Nicolas Detry, a specialized Heritage Architect. N. Detry wrote the main corpus of the section on “Formativity of the Abode of Chaos” with reference to the work of Luigi Pareyson. Raphaëlle Rivière, historian of art & architecture and archaeologist, studied the Total Work of Art (Gesamtkunstwerk) and the Singular Architecture that is the Abode of Chaos / Demeure du Chaos with Nicolas Detry. They were both also the curators of the exhibition “The Abode of Chaos: History of a Sustainable Heritage from the 17th Century to the Present Day” in 2022.

Finally, from a purely pedagogical perspective, the notion ‘total work of art’ (from the German Gesamtkunstwerk) that Madame Rachida Dati, Minister of Culture, has officially recognized in the Abode of Chaos, is an aesthetic concept originating from German romanticism and appearing in the 19th century in Europe. A ‘total work of art’ is characterized by the simultaneous use of numerous artistic mediums and disciplines, and by the symbolic, philosophical or metaphysical significance it holds. Such projects are born from a desire to reflect the interconnectedness of all elements of existence.

thierry Ehrmann opens the doors of the total artwork La Demeure du Chaos to Loïc Ballet & Sébastien Chabal for the TV program En vadrouille on March 9, 2025 (France 3 Auvergne-Rhône-Alpes, France Télévisions group, LB Production):

https://www.youtube.com/watch?v=nF_W2e4NeCc 

thierry Ehrmann’s Abode of Chaos is regularly cited by art historians as the artistic continuity of the Merzbau, a monumental spatial assemblage, the culmination of the ‘total work of art’ that the artist Kurt Schwitters worked on in his studio and home in Hanover as of 1923.

At the same time, a number of other studies were conducted, notably on the conservation and restoration of the corpus of works at La Demeure du Chaos. The eminent specialist, Simona Sajeva, a civil engineer and international specialist in the conservation-restoration of historic buildings, and President of the International Scientific Committee on Mural Paintings of ICOMOS (International Council of Monuments and Sites) played a key role in these studies.

La Demeure du Chaos is regularly included in international nominations for selections such as the Watch List of the World Monument Fund proposed by the DIVA (Documentation Interpretation and VAlorization of Heritage) research laboratory of Liège University in Belgium. The DIVA specializes in conservation sciences for art and architecture under the direction of Claudine Houbart, professor, architect, art historian, and specialist in the conservation of monuments and sites. She is also a Doctor in engineering sciences, and President of the Doctoral School at the FNRS (Scientific Research Fund) dedicated to building arts and urban planning, and a member of the ICOMOS International Scientific Committee on the theory and philosophy of conservation.

This nomination benefited from prestigious sponsorships including the support of Giovanni Carbonara (1942-2023) – professor, architect and Director Emeritus of the School of Specialization of Architectural Heritage and Landscape at the University of Rome, “La Sapienza”, and Special Advisor to UNESCO – and Pierre Hallot – Doctor of Philosophy and Geospatial Information Sciences, professor at Liège University, member of ICOMOS, expert and Belgian Representative of the CIPA (International Committee of Architectural Photogrammetry – Heritage Documentation).

In addition, La Demeure du Chaos has been subject to restoration after thierry Ehrmann reluctantly agreed to the destruction of part of his works to comply with requests from the public authorities. This work was conducted by specialists in listed monuments, including the company Comte (Vinci Group), which, among other projects, has restored the Primatiale Saint Jean in Lyon on several occasions, a UNESCO World Heritage site.

The memory of this artistic loss will remain in the martyred heritage thanks to the “Catalogue Raisonné of an Artistic Loss Necessary for Republican Peace” created in 2023, which lists the 450 destroyed works.

Lastly, the dimentions of the “total work of art” of the Abode of Chaos include the global headquarters of Artprice by Artmarket, World Leader in Art Market Information since 1987, listed on the Paris Euronext’s regulated market, as well as Groupe Serveur (Artprice’s principal shareholder) and its legal, scientific, and press agency subsidiaries (since 1985).

The Abode of Chaos is also home to the world’s largest collection of manuscripts, codices and art market sales catalogs kept under exceptionally high security standards. These documents represent the history of the art market from 1700 to the present day, a modern-day ‘Library of Alexandria‘. All the archives belong to Artprice by Artmarket and they have all been scanned annotated and studied by the company’s historians and experts. The company’s underground area also hosts its various data centers, hosting more than 180 data banks of art market information which constitute the global reference for art market professionals all over the world, and for more than 9 million Artprice by Artmarket subscribers. Artprice’s press agency, ArtMarketInsight, distributes Art Market news with its long-standing partner of 27 years, Cision PR Newswire, to 122 countries and in 11 languages.

Of the many descriptions of the Abode of Chaos proposed over the last 25 years, many art historians have used the term ‘total work of art’, while others have described it as a “Black Work of hermetic tradition feeding on the Alchemical Chaos of our tragic and sumptuous 21st century, whose embers were ignited on September 11, 2001“.

Various studies from different parts of the world suggest that the genesis of the Abode of Chaos can be traced back to first Masonic trestle boards by thierry Ehrmann at the National Grand Lodge of France in 1985, referring to the remarkable alchemical work “The Philosophers’ Mansions” by Fulcanelli.

In addition, over the last twenty-five years, thierry Ehrmann’s Abode of Chaos has regularly been compared to the famous ‘total work of art’ created by “Postman Cheval” with his “Ideal Palace”. Indeed, the reference work on Postman Cheval’s work (published by Postman Cheval’s Ideal Palace in conjunction with the École Nationale Supérieure des Beaux Arts and the Musée de la Poste in 2008) described thierry Ehrmann as The Postman Cheval of the 21st century (section titled “Cheval and his artistic lineage”, page 18). The Postman Cheval lineage is clear and unambiguous, and there exists a cultural tour incorporating visits to the two sites for more than 15 years now.

The Abode of Chaos is also home to more than 1,800 geopolitical, literary, scientific, philosophical, artistic, and historical portraits. The portraits reference personalities involved in 90% of the global news regularly covered by written and audiovisual media around the world, as well as thousands of alchemical engravings.

The international press sees the Abode of Chaos as a “body of distinct works” and as an “essential and unique ‘Factory'” that has a key place in the History of Art as the most significant major work of the beginning of the 21st century (see press review, notably the special issue of the The New York Times and Artpress).

It also exists within the realm of ideas. It has sparked exhibitions, debates, numerous books, short and feature films by renowned directors, theses, research, and reverberations across different continents.

In 2024, the 36th Congress of the International Committee of Art History (CIHA) convened in Lyon. On a global scale, the CIHA Congresses have constituted the most unifying events for the entire community of researchers and professionals in the world of art and heritage since 1873.

thierry Ehrmann, CEO and Founder of Artprice declared: “Considering our strategic mission, it is natural for Artprice and the Organe Museum of Contemporary Art that manages the Abode of Chaos, to sponsor the 36th CIHA Congress as one of its principal patrons, with contributions from all of Artprice’s historians and researchers. We were delighted to welcome delegates to the global headquarters of Artprice by Artmarket in the heart of the Organe Contemporary Art Museum and its Abode of Chaos.”

This extraordinary event for Art History, held every four years, contributed to re-emergence of France, which – according to Artprice’s 30th Annual Art Market Report – is now positioned as the second largest public art market in the world in terms of transaction volumes, just behind the United States. In 2024, Paris generated the  4th largest art auction turnover in the world, surpassing both Beijing & Shanghai. 

https://www.artprice.com/artprice-reports/the-art-market-in-2024 

Copyright 1987-2025 thierry Ehrmann www.artprice.comwww.artmarket.com

Artprice’s econometrics department can answer all your questions relating to personalized statistics and analyses: econometrics@artprice.com

Find out more about our services with the artist in a free demonstration: https://artprice.com/demo

Our services: https://artprice.com/subscription

About Artmarket.com:

Artmarket.com is listed on Eurolist by Euronext Paris. The latest TPI analysis includes more than 18,000 individual shareholders excluding foreign shareholders, companies, banks, FCPs, UCITS: Euroclear: 7478 – Bloomberg: PRC – Reuters: ARTF.

Watch a video about Artmarket.com and its Artprice department: https://artprice.com/video

Artmarket and its Artprice department were founded in 1997 by thierry Ehrmann, the company’s CEO. They are controlled by Groupe Serveur (created in 1987). cf. the certified biography from Who’s Who In France©:

https://imgpublic.artprice.com/img/wp/sites/11/2025/02/2025-Biographie_de_Thierry_Ehrmann-Who-s-Who-In-France.pdf

Artmarket is a global player in the Art Market with, among other structures, its Artprice department, world leader in the accumulation, management and exploitation of historical and current art market information (the original documentary archives, codex manuscripts, annotated books and auction catalogs acquired over the years) in databanks containing over 30 million indices and auction results, covering more than 865,100 artists.

Artprice Images® allows unlimited access to the largest art market image bank in the world with no less than 181 million digital images of photographs or engraved reproductions of artworks from 1700 to the present day, commented by our art historians.

Artmarket, with its Artprice department, constantly enriches its databases from 7,200 auction houses and continuously publishes art market trends for the main agencies and press titles in the world in 119 countries and 9 languages.

https://www.prnewswire.com/news-releases/artmarketcom-artprice-and-cision-extend-their-alliance-to-119-countries-to-become-the-worlds-leading-press-agency-dedicated-to-the-art-market-nfts-and-the-metaverse-301431845.html

Artmarket.com makes available to its 9.3 million members (members log in) the advertisements posted by its Members, who now constitute the first global Standardized Marketplace® for buying and selling artworks at fixed prices.

There is now a future for the Art Market with Artprice’s Intuitive Artmarket® AI.

Artmarket, with its Artprice department, has twice been awarded the State label “Innovative Company” by the French Public Investment Bank (BPI), which has supported the company in its project to consolidate its position as a global player in the art market.

See our 2024 Global Art Market Annual Report, published in March 2025 by Artprice by Artmarket: https://www.artprice.com/artprice-reports/the-art-market-in-2024

Artprice by Artmarket publishes its 2024 Contemporary Art Market Report:  https://www.artprice.com/artprice-reports/the-contemporary-art-market-report-2024

Summary of Artmarket press releases with its Artprice department: https://serveur.serveur.com/artmarket/press-release/en/

Follow all the Art Market news in real-time with Artmarket and its Artprice department on Facebook and Twitter:

www.facebook.com/artpricedotcom/ (more than 6.5 million subscribers)

twitter.com/artmarketdotcom

twitter.com/artpricedotcom

Discover the alchemy and the universe of Artmarket and its Artprice department: https://www.artprice.com/video

whose head office is the famous Museum of Contemporary Art Abode of Chaos dixit The New York Times / La Demeure of Chaos:

https://issuu.com/demeureduchaos/docs/demeureduchaos-abodeofchaos-opus-ix-1999-2013

La Demeure du Chaos/Abode of Chaos – Total Work of Art and Singular Architecture.
Confidential bilingual work, now made public: https://ftp1.serveur.com/abodeofchaos_singular_architecture.pdf

L’Obs – The Museum of the Future: https://youtu.be/29LXBPJrs-ohttps://www.facebook.com/la.demeure.du.chaos.theabodeofchaos999 (more than 4.1 million subscribers)https://vimeo.com/124643720

Contact Artmarket.com and its Artprice department – Contact:  Thierry Ehrmann, ir@artmarket.com

Photo – https://mma.prnewswire.com/media/2648746/Artmarket_1.jpg
Photo – https://mma.prnewswire.com/media/2648747/Artmarket_2.jpg
Photo – https://mma.prnewswire.com/media/2648748/Artmarket_3.jpg
Photo – https://mma.prnewswire.com/media/2648749/Artmarket_4.jpg
Photo – https://mma.prnewswire.com/media/2648750/Artmarket_5.jpg
Photo – https://mma.prnewswire.com/media/2648753/Artmarket_6.jpg
Logo – https://mma.prnewswire.com/media/2260897/5231985/Artmarket_logo.jpg

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/madame-rachida-dati-french-minister-of-culture-has-granted-official-recognition-to-thierry-ehrmanns-abode-of-chaos-as-a-total-work-of-art-the-global-headquarters-of-artprice-by-artmarket-302409684.html

SOURCE Artmarket.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Cryoport Reports First Quarter 2026 Financial Results

Published

on

By

First quarter revenue grew 16% year-over-year to $47.8 millionCommercial cell and gene therapy (CGT) revenue grew 26% year-over-year to $9.1 million, reflecting continued expansion in approved CGT programsLife Sciences Services revenue increased 18% year-over-year, led by 21% growth in BioStorage/BioServices Life Sciences Products revenue increased 15% year-over-year, driven by strong demand for cryogenic systems Supporting a record 766 global clinical trials and 21 commercially approved CGTs as of March 31, 2026Company raises full-year revenue guidance to $192 million – $196 million

NASHVILLE, Tenn., May 4, 2026 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its first quarter (Q1) of 2026.

Jerrell Shelton, CEO of Cryoport, commented, “Cryoport delivered a strong start to 2026 with first-quarter revenue of $47.8 million, up 16% year-over-year, reflecting a continuation of our momentum over the past several quarters across our integrated services and products platform. Revenue in support of commercial Cell and Gene Therapies (CGT) grew 26% to $9.1 million, while clinical trial support revenue grew 18% to $12.9 million. We continue to support one of the industry’s broadest CGT pipelines, and our leadership across both clinical and commercial programs positions us well for sustainable growth.

“Our Life Sciences Services segment delivered another strong quarter, with revenue increasing 18% year-over-year, including 21% growth in BioStorage/BioServices. This performance reflects the increasing scope and complexity of the Cell & Gene Therapy programs we support and underscores the critical role we play in supporting our clients with our integrated, temperature-controlled supply chain services.

“Our Life Sciences Products segment also performed very well, generating 15% revenue growth, driven by global demand for MVE Biological Solutions’ cryogenic systems. MVE continues to innovate and further solidify its position as the global leader in high-quality cryogenic systems.

“This growth across both our reporting segments, combined with solid gross margins and continued operational discipline, drove a $2.2 million year-over-year improvement in adjusted EBITDA from continuing operations, advancing us meaningfully along our “pathway to profitability.”

“Looking ahead, we see multiple growth catalysts extending beyond 2026, including the planned launch of BioServices operations at our Global Supply Chain Center in Paris, France in the third quarter, and the planned opening of our new Global Supply Chain Center in Santa Ana, California in the fourth quarter. These strategic investments expand our global footprint in key geographies and further strengthen our ability to support the advancement and commercialization of life-saving therapies globally. Reflecting on our strong performance in the first quarter and increased visibility into the remainder of the year, we are raising our full-year revenue guidance to $192 million to $196 million,” concluded Mr. Shelton.

The following table presents Q1 2026 revenue compared with Q1 2025:

Cryoport, Inc. and Subsidiaries

Revenue 

Three Months Ended
March 31,
(unaudited)

(in thousands)

2026

2025

% Change

Life Sciences Services

$              26,898

$              22,865

18 %

BioLogistics Solutions

21,668

18,531

17 %

BioStorage/BioServices 

5,230

4,334

21 %

Life Sciences Products

$              20,900

$              18,175

15 %

Total Revenue

$              47,798

$              41,040

16 %

BioLogistics Solutions revenue increased 17% year-over-year in Q1 2026, driven by increasing customer activity, continued commercial product maturation, and clinical advancement within the CGT market. BioStorage/BioServices revenue grew 21% year-over-year, reflecting strong demand for our expanded, integrated services offering, which provides seamless, secure handling of temperature-sensitive materials across our global network.

Revenue from the support of commercial CGTs increased 26% year-over-year to $9.1 million and as of March 31, 2026, the number of commercial therapies we support increased to 21.

As of March 31, 2026, Cryoport supported a total of 766 global clinical trials, a net increase of 55 clinical trials over March 31, 2025, with 91 of these clinical trials in Phase 3. The number of trials by phase and region are as follows: 

Cryoport Supported Clinical Trials by Phase

Clinical Trials

March 31,

2024

2025

2026

Phase 1

286

304

318

Phase 2

312

328

357

Phase 3

77

79

91

Total

675

711

766

Cryoport Supported Clinical Trials by Region

Clinical Trials

March 31,

2024

2025

2026

Americas

518

544

569

EMEA

112

118

143

APAC

45

49

54

Total

675

711

766

In Q1 2026, four Biologics License Applications (BLA) / Marketing Authorization Applications (MAA) filings occurred. During the first quarter, Cryoport’s customer, Rocket Pharmaceuticals, received U.S. Food and Drug Administration (FDA) accelerated approval for their gene therapy KRESLADI™ for the treatment of pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I). Severe LAD-I is an ultra-rare, life-threatening pediatric genetic immunodeficiency characterized by recurrent infections and high early-childhood mortality without treatment. For the balance of 2026, we anticipate another 10 possible BLA/MAA application filings and 8 additional new therapy approvals.

Operational milestones

Life Sciences Services

BioServices launch at our Global Supply Chain Center in Paris, France, expected in Q3, 2026.Continued progress toward the launch of our state-of-the-art Global Supply Chain Center in Santa Ana, California, expected in Q4, 2026.First cryopreserved clinical trial patient materials shipped in Q1 for two of our clients at our IntegriCell® facilities in Belgium and the U.S.Cryoport Systems named Best Logistics & Supply Chain Management Supplier – Digital Technology & Software at the 2026 Asia Pacific Biopharma Excellence Awards in Singapore.

Life Sciences Products

MVE Biological Solutions (MVE) introduced its new Fusion® 800 Series, the next evolution of MVE’s patented, award-winning Fusion technology, a self-sustaining cryogenic freezer that eliminates the need for a continuous liquid nitrogen (LN₂) supply feed, delivering exceptional reliability, safety, and sustainability in a compact footprint designed for space-constrained environments.Release of MVE HE (High Efficiency) cryogenic storage systems series integrated with the new MVE CryoVerse™ Connect Controller platform.

Financial Highlights

On June 11, 2025, the Company completed the divestiture of its CRYOPDP specialty courier business to DHL Group as part of a strategic partnership. The results of CRYOPDP, a former business within Cryoport’s Life Sciences Services segment, are presented as discontinued operations for all periods and are excluded from the non-GAAP financial measures in this release.

Revenue

Total revenue for Q1 2026 was $47.8 million, compared to $41.0 million for Q1 2025, a year-over-year increase of 16%, or $6.8 million. Life Sciences Services revenue for Q1 2026 (representing 56% of our total revenue) was $26.9 million, compared to $22.9 million for Q1 2025, up 18% year-over-year, including BioStorage/BioServices revenue of $5.2 million, up 21% year-over-year. Life Sciences Products revenue for Q1 2026 (representing 44% of our total revenue) was $20.9 million, compared to $18.2 million for Q1 2025, up 15% year-over-year.

Gross Margin

Total gross margin was 45.8% for Q1 2026, compared to 45.4% for Q1 2025. Gross margin for Life Sciences Services was 48.9% for Q1 2026, compared to 47.9% for Q1 2025. Gross margin for Life Sciences Products was 41.9% for Q1 2026, compared to 42.3% for Q1 2025.

Operating Costs and Expenses

Operating costs and expenses were $31.5 million for Q1 2026, compared to $25.8 million for Q1 2025.

Loss from Continuing Operations

Loss from continuing operations was $9.4 million for Q1 2026, compared to a loss of $6.7 million for Q1 2025.

Net Loss – including Discontinued Operations

Net loss was $10.5 million for Q1 2026, compared to net loss of $12.0 million for Q1 2025.Net loss attributable to common stockholders for Q1 2026 was $12.5 million, or $0.25 per share, compared to net loss attributable to common stockholders of $14.0 million, or $0.28 per share for Q1 2025.

Adjusted EBITDA from Continuing Operations

Adjusted EBITDA from continuing operations was a negative $0.6 million for Q1 2026, compared to a negative $2.8 million for Q1 2025.

Cash, Cash equivalents, and Short-Term Investments

Cryoport held $403.6 million in cash, cash equivalents, and short-term investments as of March 31, 2026.

Note: All reconciliations of GAAP to adjusted (non-GAAP) figures above are detailed in the reconciliation tables included later in the press release.

Additional Information

Further information on Cryoport’s financial results is included in the attached condensed consolidated balance sheets and statements of operations, and additional explanations of Cryoport’s financial performance are provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, which is expected to be filed with the SEC on May 4, 2026. Additionally, the full report will be available in the SEC Filings section of the Investor Relations section of Cryoport’s website at www.cryoportinc.com.

Earnings Conference Call Information

IMPORTANT INFORMATION: In addition to the earnings release, a document titled “Cryoport First Quarter 2026 in Review”, providing a review of Cryoport’s business update, will be issued at 4:05 p.m. ET on Monday, May 4, 2026. The document is designed to be read in advance of the questions and answers conference call and will be accessible at https://ir.cryoportinc.com/news-events/ir-calendar.

Cryoport management will host a conference call at 5:00 p.m. ET on May 4, 2026. The conference call will be in the format of a questions and answers session and will address any queries investors have regarding the Company’s reported results. A slide deck will accompany the call.

Conference Call Information

Date:

Monday, May 4, 2026

Time:

5:00 p.m. ET

Dial-in numbers:

1-800-717-1738 (U.S.), 1-646-307-1865 (International)

Confirmation code:

Request the “Cryoport Call” or Conference ID: 1191652

Live webcast:

‘Investor Relations’ section at www.cryoportinc.com or click here.


Please allow 10 minutes prior to the call to visit this site to download and install any necessary audio software.

The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company’s website at www.cryoportinc.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until May 11, 2026. To access the replay, dial 1-844-512-2921 (United States) or 1-412-317-6671 (International) and enter replay entry code: 1191652#.

About Cryoport, Inc.

Cryoport, Inc. (Nasdaq: CYRX) is a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine. We support biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products designed to minimize risk and maximize reliability across the temperature-controlled supply chain for the life sciences. Our integrated supply chain platform includes the Cryoportal® Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, cryopreservation services, and cryogenic systems, which in varying combinations deliver end-to-end solutions that meet the rigorous demands of the life sciences. With innovation, regulatory compliance, and agility at our core, we are “Enabling the Future of Medicine™.” 

Headquartered in Nashville, Tennessee, our company maintains a strong global presence with operations across the Americas, EMEA, and APAC.

For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X, formerly known as Twitter at https://x.com/cryoport for live updates.

Forward-Looking Statements

Statements in this press release which are not purely historical, including statements regarding the Company’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, those related to the Company’s industry, business, long-term growth prospects, plans, strategies, acquisitions, future financial results and financial condition, such as the Company’s outlook and guidance for full-year 2026 revenue and the related assumptions and factors expected to drive revenue, projected growth trends in the markets in which the Company operates, the Company’s plans and expectations regarding the launch of new products and services, such as the expected timing and benefits of such products and services launches, the Company’s expectations about future benefits of its acquisitions, and anticipated regulatory filings, approvals, label/geographic expansions or moves to earlier lines of treatment approved with respect to the products of the Company’s clients. Forward-looking statements also include those related to the Company’s expectations about future benefits relating to the CRYOPDP divestiture and strategic partnership with DHL (collectively, the “DHL Transaction”), the Company’s plans regarding its Global Supply Chain Centers, including expected timing of future openings, the Company’s plans and expectations relating to its strategic pivot to expand its global partnerships, and the Company’s expectation of revenue contribution from IntegriCell’s cryopreservation service centers throughout 2026. It is important to note that the Company’s actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effects of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, tariffs and other trade restrictions, foreign currency fluctuations, trends in the products markets, any U.S federal government shutdown, variations in the Company’s cash flow, market acceptance risks, and technical development risks. Additional risks and uncertainties relating to the DHL Transaction include, but are not limited to, the risk that any disruption resulting from the DHL Transaction may adversely affect our businesses and business relationships, including with employees and suppliers. The Company’s business could be affected by other factors discussed in the Company’s SEC reports, including in the “Risk Factors” section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and the Company cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, the Company disclaims any obligation and does not undertake to update or revise any forward-looking statements in this press release.

Cryoport, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

Three Months Ended
March 31,
(unaudited)

(in thousands, except share and per share data)

2026

2025

Revenue

Life Sciences Services revenue

$                   26,898

$                   22,865

Life Sciences Products revenue

20,900

18,175

Total revenue

47,798

41,040

Cost of revenue:

Cost of services revenue

13,747

11,920

Cost of products revenue

12,138

10,479

Total cost of revenue

25,885

22,399

Gross margin

21,913

18,641

Operating costs and expenses:

Selling, general and administrative

27,620

21,901

Engineering and development

3,907

3,934

Total operating costs and expenses:

31,527

25,835

Loss from operations

(9,614)

(7,194)

Other income (expense):

Investment income

3,090

1,573

Interest expense

(432)

(583)

Other expense, net

(2,368)

(300)

Loss before provision for income taxes

(9,324)

(6,504)

Provision for income taxes

(108)

(234)

Loss from continuing operations

$                   (9,432)

$                   (6,738)

Loss from discontinued operations, net

(1,112)

(5,243)

Net loss

$                 (10,544)

$                 (11,981)

Paid-in-kind dividend on Series C convertible preferred stock

(2,000)

(2,000)

Net loss attributable to common stockholders

$                 (12,544)

$                 (13,981)

Net loss per share attributable to common stockholders – basic and diluted

$                     (0.25)

$                     (0.28)

Weighted average common shares issued and outstanding – basic and diluted

49,897,817

49,947,012

 

Cryoport, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

March 31,

December 31,

2026

2025

(in thousands)

(unaudited)

Current assets

Cash and cash equivalents

$                     272,912

$                     250,494

Short-term investments

130,722

160,714

Accounts receivable, net

39,004

33,359

Inventories

21,750

23,188

Prepaid expenses and other current assets

6,147

8,419

Total current assets

470,535

476,174

Property and equipment, net

89,805

85,448

Operating lease right-of-use assets

39,299

39,720

Intangible assets, net

138,721

138,082

Goodwill

22,137

22,400

Deposits

2,046

2,092

Deferred tax assets

1,066

1,073

 Total assets 

$                     763,609

$                     764,989

Current liabilities

Accounts payable and other accrued expenses                                         

$                       15,937

$                       15,283

Accrued compensation and related expenses

17,007

12,980

Deferred revenue

2,314

943

Current portion of operating lease liabilities

3,641

4,133

Current portion of finance lease liabilities

419

422

Current portion of convertible senior notes, net

185,390

185,094

Current portion of notes payable

159

163

Total current liabilities

224,867

219,018

Notes payable, net

1,027

1,087

Operating lease liabilities, net

39,173

39,078

Finance lease liabilities, net

680

741

Deferred tax liabilities

1,580

1,354

Other long-term liabilities

663

444

Contingent consideration

630

629

Total liabilities

268,620

262,351

Total stockholders’ equity

494,989

502,638

Total liabilities and stockholders’ equity

$                     763,609

$                     764,989

Note Regarding Use of Non-GAAP Financial Measures

To supplement our financial statements, which are presented on the basis of U.S. generally accepted accounting principles (GAAP), the following non-GAAP measure of financial performance as defined in Regulation G of the Securities Exchange Act of 1934 is included in this release: adjusted EBITDA from continuing operations. Non-GAAP financial measures are not calculated in accordance with GAAP, are not based on any comprehensive set of accounting rules or principles and may be different from non-GAAP financial measures presented by other companies. Non-GAAP financial measures, including adjusted EBITDA from continuing operations, should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.

Adjusted EBITDA from continuing operations is defined as loss from continuing operations adjusted for net interest expense, income taxes, depreciation and amortization expense, stock-based compensation expense, acquisition and integration costs, cost reduction initiatives, investment income, unrealized loss on investments, foreign currency loss, changes in fair value of contingent consideration and charges or gains resulting from non-recurring events, as applicable.

Management believes that adjusted EBITDA from continuing operations provides a useful measure of Cryoport’s operating results, a meaningful comparison with historical results and with the results of other companies, and insight into Cryoport’s ongoing operating performance. Further, management and the Company’s board of directors utilize adjusted EBITDA from continuing operations to gain a better understanding of Cryoport’s comparative operating performance from period to period and as a basis for planning and forecasting future periods. Adjusted EBITDA from continuing operations is also a significant performance measure used by Cryoport in connection with its incentive compensation programs. Management believes adjusted EBITDA from continuing operations, when read in conjunction with Cryoport’s GAAP financials, is useful to investors because it provides a basis for meaningful period-to-period comparisons of Cryoport’s ongoing operating results, including results of operations, against investor and analyst financial models, helps identify trends in Cryoport’s underlying business and in performing related trend analyses, and it provides a better understanding of how management plans and measures Cryoport’s underlying business.

Cryoport, Inc. and Subsidiaries

Reconciliation of GAAP loss from continuing operations to adjusted EBITDA

(unaudited)

Three Months Ended
March 31,

2026

2025

(in thousands)

GAAP loss from continuing operations

$          (9,432)

$            (6,738)

Non-GAAP adjustments to loss:

Depreciation and amortization expense

6,402

6,134

Acquisition and integration costs

1

Cost reduction initiatives

216

Investment income

(3,090)

(1,573)

Unrealized loss on investments

2,105

193

Foreign currency loss

454

245

Interest expense, net

432

583

Stock-based compensation expense

2,395

3,064

Change in fair value of contingent consideration

15

(5,178)

Income taxes

108

234

Adjusted EBITDA from continuing operations

$             (611)

$            (2,819)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-reports-first-quarter-2026-financial-results-302761639.html

SOURCE Cryoport, Inc.

Continue Reading

Technology

Aviat Networks Announces Fiscal 2026 Third Quarter and Nine Month Financial Results

Published

on

By

Total Q3 QTD Revenues of $100.0 million

Q3 QTD Operating Income of $0.9 million; Q3 QTD Non-GAAP Operating Income of $3.0 million

Q3 QTD Net Earnings of $(2.1) million; Q3 QTD Adjusted EBITDA of $4.4 million

Q3 QTD Diluted Earnings per Share of $(0.16); Q3 QTD Non-GAAP Diluted Earnings per Share of $0.06

AUSTIN, Texas, May 4, 2026 /PRNewswire/ — Aviat Networks, Inc. (“Aviat Networks,” “Aviat,” or the “Company”), (Nasdaq: AVNW), the leading expert in wireless transport and access solutions, today reported financial results for its fiscal 2026 third quarter ended March 27, 2026.

Third Quarter Highlights

Recorded fiscal 2026 year-to-date revenue growth for the first nine months in North America of $2.1 million or 1.4% compared to the same nine-month period of fiscal 2025Increased year-to-date GAAP operating income to $13.4 million compared to $1.7 million in the comparable year-to-date period last yearReduced quarterly GAAP operating expenses by $1.7 million and Non-GAAP operating expenses by $0.8 million versus the year-ago periodMaintained a trailing-twelve month book-to-bill ratio greater than 1.0

Third Quarter QTD Financial Highlights

Total Revenues: $100.0 millionGAAP Results: Gross Margin 29.3%; Operating Expenses $28.3 million; Operating Income $0.9 million; Net Loss $2.1 million; Net Loss per diluted share (“Net Loss per share”) $0.16Non-GAAP Results: Adjusted EBITDA $4.4 million; Gross Margin 29.4%; Operating Expenses $26.4 million; Operating Income $3.0 million; Net Income $0.7 million; Net Income per share $0.06Cash and cash equivalents: $78.1 millionNet debt: $26.1 million

Fiscal 2026 Third Quarter and Nine Months Ended March 27, 2026

Revenues

The Company reported total revenues of $100.0 million for its fiscal 2026 third quarter, compared to $112.6 million in the fiscal 2025 third quarter, a decrease of $12.6 million or 11.2%. North America revenue of $46.2 million decreased by $3.2 million or 6.6%, compared to $49.4 million in the prior year due to timing of certain private and mobile network projects. International revenue of $53.8 million decreased by $9.4 million or 14.9%, compared to $63.2 million in the prior year, due to timing of capital expenditure plans of mobile network operators and revenue delays related to the conflict in the Middle East.

For the nine months ended March 27, 2026, revenue decreased by 0.1% to $318.8 million, compared to $319.3 million in the same period of fiscal 2025. North America revenue of $151.7 million increased by $2.1 million or 1.4%, compared to $149.6 million in the same period of fiscal 2025. International revenue of $167.1 million decreased by $2.6 million or 1.5% as compared to $169.7 million in the same period of fiscal 2025.

Gross Margins

In the fiscal 2026 third quarter, the Company reported GAAP gross margin of 29.3% and non-GAAP gross margin of 29.4%. This compares to GAAP gross margin of 34.9% and non-GAAP gross margin of 35.8% in the fiscal 2025 third quarter, a decrease of 560 and 640 basis points, respectively. The decrease was driven by regional and product mix in the quarter.

For the nine months ended March 27, 2026, the Company reported GAAP gross margin of 31.7% and non-GAAP gross margin of 32.1%. This compares to GAAP gross margin of 31.3% and non-GAAP gross margin of 32.1% in the same period of fiscal 2025, an increase of 40 and 0 basis points, respectively.

Operating Expenses

The Company reported GAAP total operating expenses of $28.3 million for the fiscal 2026 third quarter, compared to $30.0 million in the fiscal 2025 third quarter. Non-GAAP total operating expenses, excluding the impact of restructuring charges, share-based compensation, and merger and acquisition and other expenses for the fiscal 2026 third quarter were $26.4 million, compared to $27.2 million in the prior year, a decrease of $0.8 million or 3.1%.

For the nine months ended March 27, 2026, the Company reported total operating expenses of $87.6 million, compared to $98.3 million in the same period of fiscal 2025, a decrease of $10.6 million or 10.8%. Non-GAAP total operating expenses, excluding the impact of restructuring charges, share-based compensation, and merger and acquisition expenses and other expenses for the nine months ended March 27, 2026 were $81.9 million, compared to $86.4 million in the same period of fiscal 2025, a decrease of $4.5 million or 5.2%.

Operating Income

The Company reported GAAP operating income of $0.9 million for the fiscal 2026 third quarter, compared to GAAP operating income of $9.3 million in the fiscal 2025 third quarter, a decrease of $8.4 million. Operating income decreased primarily due to lower gross margin dollars. On a non-GAAP basis, the Company reported operating income of $3.0 million for the fiscal 2026 third quarter, compared to non-GAAP operating income of $13.0 million in the prior year, a decrease of $10.1 million.

For the nine months ended March 27, 2026, the Company reported a GAAP operating income of $13.4 million, compared to a GAAP operating income of $1.7 million in the same period of fiscal 2025, an increase of $11.7 million. On a non-GAAP basis, the Company reported operating income of $20.5 million, compared to an operating income of $16.1 million in the same period of fiscal 2025, an increase of $4.4 million.

Net Income / Net Income Per Share

The Company reported GAAP net loss of $2.1 million in the fiscal 2026 third quarter or GAAP net loss per share of $0.16. This compared to GAAP net income of $3.5 million or GAAP net income per share of $0.27 in the fiscal 2025 third quarter. On a non-GAAP basis, the Company reported non-GAAP net income of $0.7 million or non-GAAP net income per share of $0.06, compared to non-GAAP net income of $11.3 million or $0.88 per share in the prior year.

The Company reported GAAP net income of $3.8 million for the nine months ended March 27, 2026, or GAAP net income per diluted share of $0.29. This compared to GAAP net loss of $3.9 million or $0.30 per share in the comparable fiscal 2025 period. On a non-GAAP basis, the Company reported net income of $13.3 million or net income per share of $1.02 for the nine months ended March 27, 2026, as compared to non-GAAP net income of $10.6 million or $0.83 per share in the comparable fiscal 2025 period.

Adjusted EBITDA

Adjusted earnings before interest, tax, depreciation and amortization (“Adjusted EBITDA”) for the fiscal 2026 third quarter was $4.4 million, compared to $14.9 million in the fiscal 2025 third quarter.

For the nine months ended March 27, 2026, the Company reported Adjusted EBITDA of $24.8 million, as compared to $22.0 million in the comparable fiscal 2025 period, an increase of $2.8 million.

Balance Sheet Highlights

The Company reported $78.1 million in cash and cash equivalents as of March 27, 2026, compared to $59.7 million as of June 27, 2025, an increase of $18.4 million. As of March 27, 2026, total debt was $104.3 million, an increase of $16.7 million from June 27, 2025.

Fiscal 2026 Full Year Outlook

The Company is updating its fiscal 2026 full year guidance to:

Full year Revenue between $428 and $440 millionFull year Adjusted EBITDA between $35.0 and $40.0 million

Conference Call Details

Aviat Networks will host a conference call at 5:00 p.m. Eastern Time (ET) today, May 4, 2026, to discuss its financial and operational results for the fiscal 2026 third quarter ended March 27, 2026. Participating on the call will be Peter Smith, President and Chief Executive Officer; Andy Schmidt, Senior Vice President and Chief Financial Officer; Jonanna Mikulenka, Vice President and Chief Accounting Officer; and Andrew Fredrickson, Vice President, Corporate Finance. Following management’s remarks, there will be a question and answer period.

Interested parties may access the conference call live via the webcast through Aviat Network’s Investor Relations website at investors.aviatnetworks.com/events-and-presentations/events, or may participate via telephone by registering using this online form. Once registered, telephone participants will receive the dial-in number along with a unique PIN number that must be used to access the call. A replay of the conference call webcast will be available after the call on the Company’s investor relations website.

About Aviat Networks

Aviat Networks, Inc. is the leading expert in wireless transport and access solutions and works to provide dependable products, services and support to its customers. With more than one million systems sold into 170 countries worldwide, communications service providers and private network operators including state/local government, utility, federal government and defense organizations trust Aviat with their critical applications. Coupled with a long history of microwave innovations, Aviat provides a comprehensive suite of localized professional and support services enabling customers to drastically simplify both their networks and their lives. For more than 70 years, the experts at Aviat have delivered high performance products, simplified operations, and the best overall customer experience. Aviat is headquartered in Austin, Texas. For more information, visit www.aviatnetworks.com or connect with Aviat Networks on Facebook and LinkedIn.

Forward-Looking Statements

The information contained in this Current Report on Form 8-K includes forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including Aviat’s beliefs and expectations regarding outlook, business conditions, new product solutions, customer positioning, future orders, bookings, new contracts, cost structure, profitability in fiscal 2026, its recent acquisitions and acquisition strategy, process improvements, measures designed to improve internal controls, its ability to maintain effective internal control over financial reporting and management systems and remediate material weaknesses, plans and objectives of management, realignment plans and review of strategic alternatives and expectations regarding future revenue, gross margin, Adjusted EBITDA, operating income or earnings or loss per share. All statements, trend analyses and other information contained herein regarding the foregoing beliefs and expectations, as well as about the markets for the services and products of Aviat and trends in revenue, and other statements identified by the use of forward-looking terminology, including “anticipate,” “believe,” “plan,” “estimate,” “expect,” “goal,” “will,” “see,” “continue,” “delivering,” “view,” and “intend,” or the negative of these terms or other similar expressions, constitute forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, forward-looking statements are based on estimates reflecting the current beliefs, expectations and assumptions of the senior management of Aviat regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Such forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. Forward-looking statements should therefore be considered in light of various important factors, including those set forth in this document. Therefore, you should not rely on any of these forward-looking statements.

Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include the following: the disruption the 4RF and NEC transactions may cause to customers, vendors, business partners and our ongoing business; our ability to integrate the operations of the acquired 4RF and NEC businesses with our existing operations and fully realize the expected synergies of the 4RF and NEC transactions on the expected timeline; disruptions relating to the ongoing conflict between Russia and Ukraine and the conflict in Israel and surrounding areas; continued price and margin erosion in the microwave transmission industry; the impact of the volume, timing, and customer, product, and geographic mix of our product orders; our ability to meet financial covenant requirements; the timing of our receipt of payment; our ability to meet product development dates or anticipated cost reductions of products; our suppliers’ inability to perform and deliver on time, component shortages, or other supply chain constraints; the effects of inflation; customer acceptance of new products; the ability of our subcontractors to timely perform; weakness in the global economy affecting customer spending; retention of our key personnel; our ability to manage and maintain key customer relationships; uncertain economic conditions in the telecommunications sector combined with operator and supplier consolidation; our failure to protect our intellectual property rights or defend against intellectual property infringement claims; the results of our restructuring efforts; the effects of currency and interest rate risks; the ability to preserve and use our net operating loss carryforwards; the effects of current and future government regulations; general economic conditions, including uncertainty regarding the timing, pace and extent of an economic recovery in the United States and other countries where we conduct business; the conduct of unethical business practices in developing countries; the impact of political turmoil in countries where we have significant business; our ability to realize the anticipated benefits of any proposed or recent acquisitions; the impact of tariffs, the adoption of trade restrictions affecting our products or suppliers, a United States withdrawal from or significant renegotiation of trade agreements, the occurrence of trade wars, the closing of border crossings, and other changes in trade regulations or relationships; our ability to implement our stock repurchase program or that it will enhance long-term stockholder value; and the impact of adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions.

For more information regarding the risks and uncertainties for Aviat’s business, see “Risk Factors” in Aviat’s Form 10-K for the fiscal year ended June 27, 2025 filed with the U.S. Securities and Exchange Commission (“SEC”) on September 10, 2025, as well as other reports filed by Aviat with the SEC from time to time. Aviat undertakes no obligation to update publicly any forward-looking statement, whether written or oral, for any reason, except as required by law, even as new information becomes available or other events occur in the future.

Investor Relations:
Andrew Fredrickson
Email: investorinfo@aviatnet.com 

 

Table 1

AVIAT NETWORKS, INC.

Fiscal Year 2026 Third Quarter Summary

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months Ended

Nine Months Ended

(In thousands, except per share amounts)

March 27,
2026

March 28,
2025

March 27,
2026

March 28,
2025

Revenues:

Product sales

$          68,405

$          76,824

$        224,699

$        220,252

Services

31,598

35,816

94,096

99,014

Total revenues

100,003

112,640

318,795

319,266

Cost of revenues:

Product sales

51,009

51,370

158,155

158,540

Services

19,711

21,974

59,593

60,756

Total cost of revenues

70,720

73,344

217,748

219,296

Gross profit

29,283

39,296

101,047

99,970

Operating expenses:

Research and development

7,656

7,704

21,163

28,334

Selling and administrative

20,365

22,121

66,125

68,348

Restructuring charges

323

177

344

1,592

Total operating expenses

28,344

30,002

87,632

98,274

Operating income

939

9,294

13,415

1,696

Interest expense, net

1,848

1,557

5,468

4,252

Other expense (income), net

1,400

3,068

(371)

4,047

(Loss) income before income taxes

(2,309)

4,669

8,318

(6,603)

(Benefit from) provision for income taxes

(244)

1,141

4,503

(2,747)

Net (loss) income

$          (2,065)

$           3,528

$           3,815

$          (3,856)

Net (loss) income per share of common stock outstanding:

Basic

$           (0.16)

$            0.28

$            0.30

$           (0.30)

Diluted

$           (0.16)

$            0.27

$            0.29

$           (0.30)

Weighted-average shares outstanding:

Basic

12,918

12,689

12,844

12,672

Diluted

12,918

12,838

13,030

12,672

 

Table 2

AVIAT NETWORKS, INC.

Fiscal Year 2026 Third Quarter Summary

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

March 27,
2026

June 27,
2025

(Unaudited)

ASSETS

Current Assets:

Cash and cash equivalents

$             78,129

$             59,690

Accounts receivable, net

187,624

180,321

Unbilled receivables

85,260

105,870

Inventories

72,609

83,979

Other current assets

26,740

33,715

Total current assets

450,362

463,575

Property, plant and equipment, net

18,990

17,453

Goodwill

19,473

19,655

Intangible assets, net

24,395

26,897

Deferred income taxes

86,977

88,149

Right-of-use assets

2,214

3,113

Other assets

14,134

14,454

Total long-term assets

166,183

169,721

Total assets

$           616,545

$           633,296

LIABILITIES AND EQUITY

Current Liabilities:

Accounts payable

$           112,063

$           148,093

Accrued expenses

40,082

38,897

Short-term lease liabilities

547

1,090

Advance payments and unearned revenue

67,845

73,735

Other current liabilities

160

1,757

Current portion of long-term debt

5,595

18,624

Total current liabilities

226,292

282,196

Long-term debt

98,668

68,966

Unearned revenue

9,724

8,063

Long-term operating lease liabilities

1,858

2,241

Other long-term liabilities

328

430

Reserve for uncertain tax positions

3,724

3,242

Deferred income taxes

4,175

4,975

Total liabilities

344,769

370,113

Commitments and contingencies

Stockholder’s equity:

Preferred stock

Common stock

129

127

Treasury stock

(7,576)

(7,076)

Additional paid-in-capital

870,340

866,119

Accumulated deficit

(573,357)

(577,172)

Accumulated other comprehensive loss

(17,760)

(18,815)

Total stockholders’ equity

271,776

263,183

Total liabilities and stockholders’ equity

$           616,545

$           633,296

 

AVIAT NETWORKS, INC.
Fiscal Year 2026 Third Quarter Summary
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND REGULATION G DISCLOSURE

To supplement the consolidated financial statements presented in accordance with accounting principles generally accepted in the United States (GAAP), we provide additional measures of gross margin, research and development expenses, selling and administrative expenses, operating expenses, operating income, provision for or benefit from income taxes, net income, net income per share, and adjusted income before interest, tax, depreciation and amortization (Adjusted EBITDA), in each case, adjusted to exclude certain costs, charges, gains and losses, as set forth below. We believe that these non-GAAP financial measures, when considered together with the GAAP financial measures provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionate positive or negative impact on results in any particular period. We also believe these non-GAAP measures enhance the ability of investors to analyze trends in our business and to understand our performance. In addition, we may utilize non-GAAP financial measures as a guide in our forecasting, budgeting and long-term planning process and to measure operating performance for some management compensation purposes. Any analysis of non-GAAP financial measures should be used only in conjunction with results presented in accordance with GAAP. Reconciliations of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP follow.

1We have not reconciled Adjusted EBITDA guidance to its corresponding GAAP measure due to the high variability and difficulty in making accurate forecasts and projections, particularly with respect to merger and acquisition costs and share-based compensation. In particular, share-based compensation expense is affected by future hiring, turnover, and retention needs, as well as the future fair market value of our common stock, all of which are difficult to predict and subject to change. Accordingly, reconciliations of forward-looking Adjusted EBITDA are not available without unreasonable effort.

 

Table 3
AVIAT NETWORKS, INC.
Fiscal Year 2026 Third Quarter Summary
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES (1)
Condensed Consolidated Statements of Operations
(Unaudited)

Three Months Ended

Nine Months Ended

March 27,
2026

% of

Revenue

March 28,
2025

% of

Revenue

March 27,
2026

% of

Revenue

March 28,
2025

% of

Revenue

(In thousands, except percentages and per share amounts)

GAAP gross margin

$        29,283

29.3 %

$       39,296

34.9 %

$   101,047

31.7 %

$    99,970

31.3 %

Share-based compensation

37

(1)

105

214

Merger and acquisition and other expenses

69

995

1,247

2,295

Non-GAAP gross margin

29,389

29.4 %

40,290

35.8 %

102,399

32.1 %

102,479

32.1 %

GAAP research and development expenses

$          7,656

7.7 %

$        7,704

6.8 %

$    21,163

6.6 %

$    28,334

8.9 %

Share-based compensation

(35)

(149)

(98)

(456)

Non-GAAP research and development expenses

7,621

7.6 %

7,555

6.7 %

21,065

6.6 %

27,878

8.7 %

GAAP selling and administrative expenses

$        20,365

20.4 %

$       22,121

19.6 %

$    66,125

20.7 %

$    68,348

21.4 %

Share-based compensation

(1,508)

(1,840)

(4,280)

(4,956)

Merger and acquisition and other expenses

(70)

(595)

(1,057)

(4,890)

Non-GAAP selling and administrative expenses

18,787

18.8 %

19,686

17.5 %

60,788

19.1 %

58,502

18.3 %

GAAP operating expense

$        28,344

28.3 %

$       30,002

26.6 %

$    87,632

27.5 %

$    98,274

30.8 %

Share-based compensation

(1,543)

(1,989)

(4,378)

(5,412)

Merger and acquisition and other expenses

(70)

(595)

(1,057)

(4,890)

Restructuring charges

(323)

(177)

(344)

(1,592)

Non-GAAP operating expense

26,408

26.4 %

27,241

24.2 %

81,853

25.7 %

86,380

27.1 %

GAAP operating income

$            939

0.9 %

$        9,294

8.3 %

$    13,415

4.2 %

$     1,696

0.5 %

Share-based compensation

1,580

1,988

4,483

5,626

Merger and acquisition and other expenses

139

1,590

2,304

7,185

Restructuring charges

323

177

344

1,592

Non-GAAP operating income

2,981

3.0 %

13,049

11.6 %

20,546

6.4 %

16,099

5.0 %

GAAP income tax (benefit) provision

$           (244)

(0.2) %

$        1,141

1.0 %

$     4,503

1.4 %

$    (2,747)

(0.9) %

Adjustment to reflect pro forma tax rate

644

(941)

(2,703)

3,947

Non-GAAP income tax provision

400

0.4 %

200

0.2 %

1,800

0.6 %

1,200

0.4 %

GAAP net (loss) income

$         (2,065)

(2.1) %

$        3,528

3.1 %

$     3,815

1.2 %

$    (3,856)

(1.2) %

Share-based compensation

1,580

1,988

4,483

5,626

Merger and acquisition and other expenses

139

1,590

2,304

7,185

Restructuring charges

323

177

344

1,592

Other expense (income), net

1,400

3,068

(371)

4,047

Adjustment to reflect pro forma tax rate

(644)

941

2,703

(3,947)

Non-GAAP net income

$            733

0.7 %

$       11,292

10.0 %

$    13,278

4.2 %

$    10,647

3.3 %

Diluted net (loss) income per share:

GAAP

$          (0.16)

$          0.27

$       0.29

$      (0.30)

Non-GAAP

$           0.06

$          0.88

$       1.02

$       0.83

Shares used in computing diluted net (loss)
income per share

GAAP

12,918

12,838

13,030

12,672

Non-GAAP

13,074

12,838

13,030

12,818

Adjusted EBITDA:

GAAP net (loss) income

$         (2,065)

(2.1) %

$        3,528

3.1 %

$     3,815

1.2 %

$    (3,856)

(1.2) %

Depreciation and amortization of property,
plant and equipment and intangible assets

1,426

1,830

4,247

5,935

Interest expense, net

1,848

1,557

5,468

4,252

Other expense (income), net

1,400

3,068

(371)

4,047

Share-based compensation

1,580

1,988

4,483

5,626

Merger and acquisition and other expenses

139

1,590

2,304

7,185

Restructuring charges

323

177

344

1,592

(Benefit from) provision for income taxes

(244)

1,141

4,503

(2,747)

Adjusted EBITDA

$          4,407

4.4 %

$       14,879

13.2 %

$    24,793

7.8 %

$    22,034

6.9 %

(1)

The adjustments above reconcile our GAAP financial results to the non-GAAP financial measures used by us. Our non-GAAP net income excluded share-based compensation, and other non-recurring charges (recovery). Adjusted EBITDA was determined by excluding depreciation and amortization on property, plant and equipment, interest, provision for or benefit from income taxes, and non-GAAP pre-tax adjustments, as set forth above, from GAAP net income. We believe that the presentation of these non-GAAP items provides meaningful supplemental information to investors, when viewed in conjunction with, and not in lieu of, our GAAP results. However, the non-GAAP financial measures have not been prepared under a comprehensive set of accounting rules or principles. Non-GAAP information should not be considered in isolation from, or as a substitute for, information prepared in accordance with GAAP. Moreover, there are material limitations associated with the use of non-GAAP financial measures.

 

Table 4
AVIAT NETWORKS, INC. 
Fiscal Year 2026 Third Quarter Summary 
SUPPLEMENTAL SCHEDULE OF REVENUE BY GEOGRAPHICAL AREA
(Unaudited)

Three Months Ended

Nine Months Ended

March 27,
2026

March 28,
2025

March 27,
2026

March 28,
2025

(In thousands)

North America

$             46,165

$             49,402

$           151,713

$     149,589

International:

Africa and the Middle East

16,446

15,086

43,868

38,210

Europe

10,333

9,429

29,318

23,376

Latin America and Asia Pacific

27,059

38,723

93,896

108,091

Total international

53,838

63,238

167,082

169,677

Total revenue

$           100,003

$           112,640

$           318,795

$     319,266

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/aviat-networks-announces-fiscal-2026-third-quarter-and-nine-month-financial-results-302761749.html

SOURCE Aviat Networks, Inc.

Continue Reading

Technology

V2X Reports First Quarter 2026 Results

Published

on

By

First Quarter Financial Highlights

Revenue of $1.25 billion, up 23% year-over-yearNet income of $18.9 million; Adjusted net income1 of $48.1 million, up 53% year-over-yearAdjusted EBITDA1 of $85.6 million; Adjusted EBITDA1 margin of 6.8%Diluted EPS of $0.60; Adjusted diluted EPS1 of $1.53, up 55% year-over-yearRecord backlog1 of $13.8 billion, driven by 3.2x book-to-bill1 in the quarter

Increasing 2026 Guidance

Increasing full-year 2026 guidance with 9% revenue and adjusted EBITDA1 growth at the midpoint

RESTON, Va., May 4, 2026 /PRNewswire/ — V2X, Inc. (NYSE:VVX) today announced first quarter 2026 financial results, and increased guidance for full-year 2026.

“V2X delivered a strong start to 2026, with double-digit growth on both the top and bottom lines, underscoring our team’s disciplined execution and our organization’s alignment to national security priorities,” said Jeremy C. Wensinger, President and Chief Executive Officer. “We secured approximately 50 awards in the quarter totaling approximately $4.1 billion, driving total backlog1 to a record $13.8 billion and reinforcing our position as a leading provider of mission capabilities. We are increasing our full-year outlook given the momentum underway. Supported by our strong balance sheet, we will continue to prioritize investments that accelerate innovation across the enterprise and enhance global operations, to deliver differentiated outcomes for customers and greater value for shareholders.”

First Quarter 2026 Results

In the first quarter, V2X reported revenue of $1.25 billion, representing year-over-year growth of 23%. The Company reported solid topline growth and strong operating performance, yielding double-digit growth in adjusted net income1 and adjusted EPS1. Net income for the quarter was $18.9 million. Adjusted net income1 was $48.1 million, an increase of 53%, year-over-year. First quarter GAAP diluted EPS was $0.60. Adjusted diluted EPS1 for the quarter increased 55% year-over-year to $1.53.

V2X delivered adjusted EBITDA1 of $85.6 million, with a margin1 of 6.8%, representing an increase of 28%, from the prior year.

First quarter net cash used by operating activities was $129.9 million. Adjusted net cash used by operating activities1 was $22.1 million.

At the end of the first quarter, net debt for V2X was $895.4 million, representing an improvement of $77 million year-over-year and a 2.5x net leverage ratio1. The Company expects to achieve a net leverage ratio1 less than 2.0x by the end of 2026.

As of April 3, 2026, total backlog1 was $13.8 billion and funded backlog1 was $2.3 billion. Book-to-bill1 in the first quarter was approximately 3.2x. Trailing twelve-month book-to-bill1 was approximately 1.5x.

Increasing 2026 Guidance

The Company is increasing its 2026 guidance ranges as follows:

$ millions, except for per share amounts

Prior 2026 Guidance

Updated 2026 Guidance

Revenue

$4,675

$4,825

$4,825

$4,975

Adjusted EBITDA1

$335

$350

$345

$360

Adjusted Diluted Earnings Per Share1

$5.50

$5.90

$5.75

$6.15

Adjusted Net Cash Provided by Operating Activities1

$150

$170

$160

$180

The Company is not providing a quantitative reconciliation with respect to the foregoing forward-looking non-GAAP measures in reliance on the “unreasonable efforts” exception set forth in SEC rules because certain financial information, the probable significance of which cannot be determined, is not available and cannot be reasonably estimated. For example, unusual, one-time, non-ordinary, or non-recurring costs, which relate to M&A, integration and related activities cannot be reasonably estimated. Forward-looking statements are based upon current expectations and are subject to factors that could cause actual results to differ materially from those suggested here, including those factors set forth in the Safe Harbor Statement below. 

First Quarter Conference Call
Management will conduct a conference call with analysts and investors at 4:30 p.m. ET on Monday, May 4, 2026. U.S.-based participants may dial in to the conference call at 877-300-8521, while international participants may dial 412-317-6026. A live webcast of the conference call as well as an accompanying slide presentation will be available here: https://app.webinar.net/Q291YZzYJpN

A replay of the conference call will be posted on the V2X website shortly after completion of the call and will be available for one year. A telephonic replay will also be available through May 18, 2026, at 844-512-2921 (domestic) or 412-317-6671 (international) with passcode 10208314. 

Presentation slides that will be used in conjunction with the conference call will also be made available online in advance on the “investors” section of the company’s website at https://gov2x.com. V2X recognizes its website as a key channel of distribution to reach public investors and as a means of disclosing material non-public information to comply with its obligations under the U.S. Securities and Exchange Commission (“SEC”) Regulation FD.

__________________________________
1 See “Key Performance Indicators and Non-GAAP Financial Measures” for descriptions and reconciliations.

About V2X
V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission’s lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,200 professionals, V2X enables mission success by injecting AI and machine learning capabilities to meet today’s toughest challenges across all operational domains.

Investor Contact

Media Contact

Mike Smith, CFA

Angelica Spanos Deoudes

IR@goV2X.com

Communications@goV2X.com

719-637-5773

571-338-5195

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 (the “Act”): Certain material presented herein includes forward-looking statements intended to qualify for the safe harbor from liability established by the Act.

Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “could,” “potential,” “continue” or similar terminology. These statements are based on the beliefs and assumptions of the management of the Company based on information currently available to management. Forward-looking statements in this press release, include, but are not limited to our future performance and capabilities; all of the statements and items listed under “Increasing 2026 Guidance” above and other assumptions contained therein for purposes of such guidance; our belief that prior performance provides substantial visibility for future performance; market trends; product development; capital deployment; future net leverage ratio; and our belief that our innovation strategy, visibility, and targeted growth opportunities provide substantial opportunities for value creation.

These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside our management’s control, which could cause actual results to differ materially from the results discussed in the forward-looking statements.  In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections. For a discussion of some of the risks and uncertainties that could cause actual results to differ from such forward-looking statements, see the risks and other factors detailed from time to time in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the SEC.

We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

V2X, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

 

Three Months Ended

April 3,

March 28,

(In thousands, except per share data)

2026

2025

Revenue

$    1,254,128

$    1,015,923

Cost of revenue

1,148,310

937,820

Selling, general, and administrative expenses

61,728

43,805

Operating income

44,090

34,298

Loss on extinguishment of debt

(2,214)

Interest expense, net

(18,125)

(19,719)

Other expense, net

(2,446)

(2,295)

Income from operations before income taxes

23,519

10,070

Income tax expense

4,594

1,963

Net income

$        18,925

$          8,107

Earnings per share

Basic

$            0.61

$            0.26

Diluted

$            0.60

$            0.25

Weighted average common shares outstanding – basic

31,214

31,590

Weighted average common shares outstanding – diluted

31,512

32,021

 

V2X, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

April 3,

December 31,

(In thousands, except per share data)

2026

2025

Assets

Current assets

 Cash, cash equivalents and restricted cash

$      208,666

$      368,994

 Receivables

828,759

738,922

 Prepaid expenses and other current assets

131,981

127,102

Total current assets

1,169,406

1,235,018

 Property, plant, and equipment, net

50,640

52,383

 Goodwill

1,676,954

1,677,154

 Intangible assets, net

217,060

239,760

 Other non-current assets

75,409

76,525

Total non-current assets

2,020,063

2,045,822

Total Assets

$    3,189,469

$    3,280,840

Liabilities and Shareholders’ Equity

Current liabilities

 Accounts payable

$      467,420

$      557,042

 Compensation and other employee benefits

170,388

176,530

 Short-term debt

14,935

14,935

 Other accrued liabilities

280,561

267,039

Total current liabilities

933,304

1,015,546

 Long-term debt, net

1,060,928

1,083,234

 Deferred tax liabilities

30,232

28,357

 Other non-current liabilities

61,462

69,067

Total non-current liabilities

1,152,622

1,180,658

Total liabilities

2,085,926

2,196,204

Commitments and contingencies (Note 7)

Shareholders’ Equity

Preferred stock; $0.01 par value; 10,000,000 shares authorized; No shares issued and outstanding

Common stock; $0.01 par value; 100,000,000 shares authorized; 31,873,847 shares issued and
31,310,209 shares outstanding as of April 3, 2026; 31,735,083 shares issued and 31,171,445 shares
outstanding as of December 31, 2025

318

317

Treasury stock, at cost – (563,638) shares as of both April 3, 2026 and December 31, 2025

(30,274)

(30,274)

Additional paid in capital

777,994

779,084

Retained earnings

362,342

343,417

Accumulated other comprehensive loss

(6,837)

(7,908)

Total shareholders’ equity

1,103,543

1,084,636

Total Liabilities and Shareholders’ Equity

$    3,189,469

$    3,280,840

 

V2X, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

Three Months Ended

April 3,

March 28,

(In thousands)

2026

2025

Operating activities

Net income

$        18,925

$          8,107

Adjustments to reconcile net income to net cash used in operating activities:

 Depreciation expense

3,963

4,250

 Amortization of intangible assets

22,900

22,562

 Amortization of cloud computing arrangements

1,246

1,226

 Loss on disposal of property, plant, and equipment

3

253

 Stock-based compensation

3,609

2,452

 Deferred taxes

1,557

(3,074)

 Amortization of debt issuance costs

1,669

1,488

 Loss on extinguishment of debt

2,214

Changes in assets and liabilities:

 Receivables

(90,701)

6,502

 Other assets

(5,348)

(6,411)

 Accounts payable

(89,372)

(107,694)

 Compensation and other employee benefits

(6,050)

(42,610)

 Other liabilities

7,689

15,271

 Net cash used in operating activities

(129,910)

(95,464)

Investing activities

Purchases of capital assets

(2,291)

(2,699)

Proceeds from the disposition of assets

90

 Net cash used in investing activities

(2,291)

(2,609)

Financing activities

Repayments of long-term debt

(23,734)

Proceeds from revolver

141,000

Repayments of revolver

(141,000)

Proceeds from stock awards and stock options

60

77

Payment of debt issuance costs

(1,223)

Payments of employee withholding taxes on stock-based compensation

(4,758)

(2,653)

 Net cash used in financing activities

(28,432)

(3,799)

Exchange rate effect on cash

305

2,613

Net change in cash, cash equivalents and restricted cash

(160,328)

(99,259)

Cash, cash equivalents and restricted cash – beginning of period

368,994

268,321

Cash, cash equivalents and restricted cash – end of period

$       208,666

$       169,062

Supplemental disclosure of cash flow information:

Interest paid

$        17,426

$        12,945

Income taxes paid

$          2,707

$            320

Purchase of capital assets on account

$          1,510

$              48

Key Performance Indicators and Non-GAAP Measures

The primary financial performance measures we use to monitor results of operations are revenue and operating income. Management believes that these financial performance measures are the primary drivers for our earnings and net cash from operating activities. Management evaluates its contracts and business performance by focusing on revenue and operating income. Operating income represents revenue less both cost of revenue and selling, general and administrative (SG&A) expenses. Cost of revenue consists of labor, subcontracting costs, materials, and an allocation of indirect costs. SG&A expenses consist of indirect labor costs (including wages and salaries for executives and administrative personnel), bid and proposal expenses and other general and administrative expenses not allocated to cost of revenue. Backlog is the estimated amount of future revenues to be recognized under negotiated contracts. Funded backlog is contractually authorized and appropriated by the customer. Bookings includes approved values formally booked into V2X’s backlog for new business contract awards including unexercised options, contract modifications, recompetes, contract extensions and add-on work to existing contracts. Book-to-bill is derived by dividing bookings by revenue.

We manage the nature and amount of costs at the program level, which forms the basis for estimating our total costs and profitability. This is consistent with our approach for managing our business, which begins with management’s assessing the bidding opportunity for each contract and then managing contract profitability throughout the performance period.

In addition to the key performance measures discussed above, we consider adjusted net income, adjusted diluted earnings per share, adjusted operating income, adjusted EBITDA, adjusted EBITDA margin, net leverage ratio and adjusted operating cash flow to be useful to management and investors in evaluating our operating performance, and to provide a tool for evaluating our ongoing operations. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. We provide this information to our investors in our earnings releases, presentations, and other disclosures.

Adjusted net income, adjusted diluted earnings per share, adjusted EBITDA, adjusted EBITDA margin, net leverage ratio, cash interest expense, net, and adjusted net cash provided by (used in) operating activities, however, are not measures of financial performance under GAAP and should not be considered a substitute for financial measures determined in accordance with GAAP.  Definitions and reconciliations of these items are provided below.

Adjusted EBITDA is defined as operating income, adjusted to exclude depreciation and amortization of intangible assets, and items that may include, but are not limited to, significant charges or credits, and unusual and infrequent non-operating items that impact current results but are not related to our ongoing operations, such as M&A, integration, and related costs.Adjusted EBITDA margin is defined as adjusted EBITDA divided by revenue.Adjusted net income is defined as net income, adjusted to exclude items that may include, but are not limited to, significant charges or credits, and unusual and infrequent non-operating items that impact current results but are not related to our ongoing operations, such as M&A, integration and related costs, amortization of acquired intangible assets, amortization of debt issuance costs, and loss on extinguishment of debt.Adjusted diluted earnings per share is defined as adjusted net income divided by the weighted average diluted common shares outstanding.Cash interest expense, net is defined as interest expense, net adjusted to exclude amortization of debt issuance costs.Adjusted net cash provided by (used in) operating activities or adjusted operating cash flow is defined as net cash provided by (or used in) operating activities adjusted to exclude infrequent non-operating items, such as M&A payments and related costs.Net leverage ratio is defined as net debt (or total debt less unrestricted cash) divided by trailing twelve-month (TTM) bank EBITDA.

Non-GAAP Tables

($K, except per share data)

Three Months Ended

April 3, 2026

March 28, 2025

Revenue

$1,254,128

$1,015,923

Net income

$18,925

$8,107

Plus:

Income tax expense

4,594

1,963

Other expense, net

2,446

2,295

Interest expense, net

18,125

19,719

Loss on extinguishment of debt

2,214

Operating income

$44,090

$34,298

Plus:

Amortization of intangible assets

22,900

22,562

M&A, integration and related costs

13,373

4,625

Adjusted operating income

$80,363

$61,485

Plus:

Depreciation and CCA amortization

5,209

5,476

Adjusted EBITDA

$85,571

$66,961

Adjusted EBITDA margin

6.8 %

6.6 %

Minus:

Cash interest expense, net

16,456

18,231

Income tax expense, as adjusted

13,366

9,234

Depreciation and CCA amortization

5,209

5,476

Other expense, net, as adjusted

2,446

2,545

Adjusted net income

$48,094

$31,475

($K, except per share data)

Three Months Ended

April 3, 2026

March 28, 2025

Diluted earnings per share

$0.60

$0.25

Plus:

M&A, integration and related costs

$0.33

0.11

Amortization of intangible assets

$0.56

0.54

Amortization of debt issuance costs and Loss on extinguishment of debt

$0.04

0.09

FMV land impairment

$—

$—

Gain on acquisition, net

$—

$(0.01)

Adjusted diluted earnings per share

$1.53

$0.98

Average shares outstanding:

Basic, as reported

31,214

31,590

Diluted, as reported

31,512

32,021

Adjusted diluted

31,512

32,021

Non-GAAP Tables

($K)

Three Months Ended

April 3, 2026

March 28, 2025

Net cash used by operating activities

$     (129,910)

$        (95,464)

Plus:

M&A, integration, and related payments

2,206

3,008

MARPA facility activity

105,628

(25,617)

Adjusted operating cash flow

$         (22,076)

$       (118,073)

($K)

TTM

April 3, 2026

Net income

$                          88,700

Plus:

Interest expense, net

78,316

Income tax expense

25,652

Depreciation and amortization

112,595

Additional permitted add-backs1

52,097

TTM Bank EBITDA

$                        357,360

($K, except ratio)

Period Ending

April 3, 2026

Total debt

$                   1,100,085

Cash, cash equivalents and restricted cash

$                      208,666

Less:

Restricted cash

(4,014)

Cash and cash equivalents

$                      204,652

Net debt

$                      895,433

TTM bank EBITDA

$                      357,360

Net leverage ratio

 2.51x

____________________________
1 Includes among other items, non-cash losses like loss on extinguishment of debt and/or lease impairments, stock compensation, transaction and integration related costs

SUPPLEMENTAL INFORMATION

Revenue by contract type, geographic region, contract relationship, and customer for the periods presented below was as follows: 

Revenue by Contract Type

 

Three Months Ended

April 3,

March 28,

%

(In thousands)

2026

2025

Change

Cost-plus and cost-reimbursable

$       752,405

$       623,213

20.7 %

Firm-fixed-price

372,759

363,950

2.4 %

Time-and-materials

128,964

28,760

348.4 %

Total revenue

$    1,254,128

$    1,015,923

 

Revenue by Geographic Region

 

Three Months Ended

April 3,

March 28,

%

(In thousands)

2026

2025

Change

United States

$       810,554

$       577,458

40.4 %

Middle East

314,333

318,345

(1.3) %

Asia

76,137

75,978

0.2 %

Europe

53,104

44,142

20.3 %

Total revenue

$    1,254,128

$    1,015,923

 

Revenue by Contract Relationship

 

Three Months Ended

April 3,

March 28,

%

(In thousands)

2026

2025

Change

Prime contractor

$    1,197,462

$       962,421

24.4 %

Subcontractor

56,666

53,502

5.9 %

Total revenue

$    1,254,128

$    1,015,923

 

Revenue by Customer

 

Three Months Ended

April 3,

March 28,

%

(In thousands)

2026

2025

Change

Army

$       440,114

$       442,136

(0.5) %

Navy

382,921

346,118

10.6 %

Air Force

167,833

99,126

69.3 %

Other

263,260

128,543

104.8 %

Total revenue

$    1,254,128

$    1,015,923

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/v2x-reports-first-quarter-2026-results-302761328.html

SOURCE V2X, Inc.

Continue Reading

Trending